RxDoctor Payments Data

Joel Tikalsky, DPM

Podiatrist · Weston, WINPI 1073500526

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 33.2% of the total. Reporting peaked in 2019 at $221 and has fallen 82.6% since, to $38 in 2025. That places this record below the midpoint for podiatrist clinicians in WI, where the typical reported total is $1,012.

$529in general payments, 2019–2025

Across 10 payments — averaging $52.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$175
  • Novo Nordisk$125
  • Organogenesis Inc.$101
  • Boston Scientific$42
  • Abbott$31
  • Electronic Waveform Lab, Inc.$24
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$529100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson3$175
Novo Nordisk1$125
Organogenesis Inc.1$101
Boston Scientific1$42
Abbott1$31
Electronic Waveform Lab, Inc.1$24
Cook Medical LLC1$16
Stryker1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$529 in reported general payments places this provider in the 40th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$64,110
Medicare patients
163
Services billed
1,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone24$152

Paid to pharmacies, not to this prescriber.

Other podiatrist in Weston

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →